Net Loss -- $7.5 million, translating to negative $0.38 per share, with an operating loss of $7 million, improved from a ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
This manuscript reports on the application of ribosome profiling (EZRA-seq and eRF1-seq) combined with massively parallel reporter assays to identify and characterize a GA-rich element associated with ...
Q3 2025 Earnings Call November 11, 2025 10:00 AM ESTCompany ParticipantsPeter Hoetzinger - Vice Chairman, Co-CEO ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsIlan Sobel - Chief Executive OfficerBar Dichter ...
Scorpio Gold Corporation (TSXV: SGN) (OTCQB: SRCRF) (FSE: RY9) (“Scorpio Gold”, “Scorpio” or the “Company”) is pleased to ...
Detailed price information for Medexus Pharmaceuticals Inc (MDP-T) from The Globe and Mail including charting and trades.
Diamond drilling at Majorodam, Suriname confirms the presence of a mineralized zone at least 800 m long at Heuvel Main in ...
Jacobin on MSNOpinion
How Big Pharma Turned FDA Approval Into a Rubber Stamp
Alberto Espay was not prepared for how his world would be upended when he published a study on the number of people who have ...
Freedom Bank Kazakhstan, a part of Freedom Holding Corp., a NASDAQ-listed finance and technology group, received the award in ...
The multimillion-dollar initiative to create an AI-empowered higher education system comes at a time when the California ...
Both Woodworth and Muldoe had long histories working with Gitanmaax members as former child protection workers with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback